Arlington, MA, United States of America

Gerhard König


Average Co-Inventor Count = 8.7

ph-index = 5

Forward Citations = 78(Granted Patents)


Location History:

  • 40235 Düsseldorf, DE (2006)
  • Arlington, MA (US) (2006 - 2008)

Company Filing History:


Years Active: 2006-2008

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Gerhard König: Innovating in Pharmaceutical Chemistry

Introduction

Gerhard König, an accomplished inventor based in Arlington, MA, has made significant contributions to the field of pharmaceutical chemistry. With a robust portfolio of five patents, König has focused on developing novel compounds that can have a profound impact on medical treatments.

Latest Patents

Among König's most recent innovations are the Morpoline-bridged indazole derivatives and the 4-amino-substituted pyrimidine derivatives. The first patent relates to unique morpholine-bridged indazole derivatives, expanding the landscape of chemical compounds in pharmaceutical applications. The second patent introduces new 4-amino-substituted pyrimidine derivatives that stimulate soluble guanylate cyclase, providing processes for their production and potential use in developing medicaments, particularly aimed at treating central nervous system diseases.

Career Highlights

Throughout his career, Gerhard König has worked with leading companies in the pharmaceutical industry, including Bayer Healthcare Aktiengesellschaft. His work has been pivotal in advancing drug development and creating novel therapeutic solutions, showcasing his expertise and dedication to innovation.

Collaborations

König has collaborated with talented individuals in the field, including colleagues like Rudy Schreiber and Achim Feurer. These partnerships have played a vital role in fostering an environment where innovative ideas can thrive and turn into groundbreaking inventions.

Conclusion

Gerhard König's contributions to pharmaceutical chemistry through his patents demonstrate his commitment to advancing medical science. Through his innovative work, he continues to inspire future generations of inventors and researchers in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…